Chunk #37 — RESULTS — Medication by OPRM1 and DAT genotypes — Alcohol induced craving (AUQ), high (SHAS)

Source

Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.

Embedded

yes

Text

There was no significant main effects of genotypes or interaction of medication group, OPRM1, and DAT genotypes on alcohol induced craving (p>0.5 for main effects and interaction) or high (p>0.5 for main effects and interaction) after the priming drink.